State Board Of Administration Of Florida Retirement System Bei Gene, Ltd. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$221.31 - $316.61 $435,980 - $623,721	-1,970 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$123.9 - $195.41 $24,780 - $39,082	200 Added 11.3%	1,970 $371,000
Q4 2019 Feb 03, 2020	BUY	$115.78 - $208.34 $204,930 - $368,761	1,770 New	1,770 $293,000

Others Institutions Holding BGNE

# of Institutions

249

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.22 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$980 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$941 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$701 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account